Patient-Centered, Direct-Access Online Care for Management of Atopic Dermatitis

Armstrong, April W.; Johnson, Mary Ann; Lin, Steven W.; Maverakis, Emanual; Fazel, Nasim; Liu, Fu‐Tong

doi:10.1001/jamadermatol.2014.2299

Cited by 78 publications

(61 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Mobile teledermatology uses cell phones to transmit images, allows for more versatility than its often more unwieldy store-and-forward counterpart, and has good concordance with the outcomes of a face-to-face visit (36–39). Teledermatology has been validated in both infectious conditions such as HIV-associated skin conditions and chronic conditions, such as atopic dermatitis (37,40). A cross-sectional survey of HIV positive patients in Botswana found that 91% of patients felt that a mobile teledermatology visit would provide the same level of care as a face-to-face visit (41).…”

Section: Improving Quality Of Care Through Innovationmentioning

confidence: 99%

Global Burden of Skin Disease: Inequities and Innovations

et al. 2017

View full text Add to dashboard Cite

Purpose of Review We review the current understanding of the burden of dermatological disease through the lens of the Global Burden of Disease project, evaluate the impact of skin disease on quality of life in a global context, explore socioeconomic implications, and finally summarize interventions towards improving quality of dermatologic care in resource-poor settings. Recent Findings The Global Burden of Disease project has shown that skin diseases continue to be the 4th leading cause of nonfatal disease burden world-wide. However, research efforts and funding do not match with the relative disability of skin diseases. International and national efforts, such as the WHO List of Essential Medicines, are critical towards reducing the socioeconomic burden of skin diseases and increasing access to care. Recent innovations such as teledermatology, point-of-care diagnostic tools, and task-shifting help to provide dermatological care to underserved regions in a cost-effective manner. Summary Skin diseases cause significant non-fatal disability worldwide, especially in resource-poor regions. Greater impetus to study the burden of skin disease in low resource settings and policy efforts towards delivering high quality care are essential in improving the burden of skin diseases.

show abstract

Section: Improving Quality Of Care Through Innovationmentioning

confidence: 99%

Global Burden of Skin Disease: Inequities and Innovations

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Zur teledermatologischen Versorgung der Psoriasis wurden insgesamt sechs kontrollierte Studien publiziert . Aus ihnen geht zusammengefasst hervor, dass die begleitende teledermatologische Versorgung von Patienten mit Psoriasis, insbesondere auch die Verlaufskontrollen über Fotos oder Videos, wirksam und Nutzen bringend sind.…”

Section: Praxis Der Teledermatologie ‐ Langfassungunclassified

Praxis der Teledermatologie

Augustin

Wimmer

Biedermann

et al. 2018

J Deutsche Derma Gesell

View full text Add to dashboard Cite

Die Teledermatologie hat in den deutschsprachigen Ländern wie auch weltweit einen zunehmenden Stellenwert und bietet aufgrund des hohen Innovationsgrades eine Vorreiter- und Vorbildfunktion für weitere telemedizinische Anwendungen anderer Fachrichtungen. Eine qualitätsgesicherte teledermatologische Behandlung ist in den deutschsprachigen Ländern praktikabel und kann zu einem relevanten Mehrnutzen in der Versorgung führen. Ihr Einsatz ist immer dann in Erwägung zu ziehen, wenn relevante Zusatznutzen für die Patienten ohne relevante Nachteile für sie und für die Versorgenden zu erwarten sind. Für die teledermatologische Behandlung wurden mit dem vorliegenden Konsensuspapier praxisrelevante Maßgaben festgelegt. Etwaige situationsabhängige Limitationen in der Versorgung sind stets zu beachten.

show abstract

“…[11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26] All studies were from high income countries. Six studies (seven articles) were from the United States, 11,15,18,21,[23][24][25] two from the Netherlands, 17,22 and one from each of the following countries: Austria, 16 Canada, 20 Denmark, 26 Italy, 12 Norway, 13 Singapore, 19 and United Kingdom.…”

Section: Clinical Outcomesmentioning

confidence: 99%

“…14 Eleven studies were randomized controlled trials [11][12][13][14][15][16]18,[20][21][22][23][24][25] (Table S3). One study used the intervention for both screening and follow-up.…”

Section: Clinical Outcomesmentioning

confidence: 99%

“…In most studies, the participants included were in the adult age, with the following exceptions: the mean age of participants was >65 years in two studies, 20,26 one included adolescents and adults, 16 one only children, and one with groups of children patients/parents of children and adult patients. 22 Four studies focused on psoriasis lesions, 12,14,15,17 three on atopic dermatitis, 11,13,22 two on patients with acne, 16,23 two on pressure ulcer, 20,21 and two on chronic skin lesions. 19,26 One study did not specify or presented the most frequent diagnosis, 18 and in one study there was a wide variety of diagnoses.…”

Section: Clinical Outcomesmentioning

confidence: 99%

See 1 more Smart Citation